Biopharmaceuticals Portfolio In A Biotech Bull Market
September 06, 2017 at 00:08 AM EDT
Biotech stocks broke through the July sector highs as tracked by major ETFs. However we are still about 25% off the July 2015 bubble highs but supported by good earnings fundamentals, strong technicals and potentially a seasonal strong Q4.
